Tag Archives: MHVYF

Top High Tech Stocks To Watch Right Now

Chambers CEO: Already Working With Trump to Kill DOL Fiduciary Rule

Is Your Broker-Dealer in a Death Spiral? 4 Steps to Discovery

Despite Rising Rates, Not All REITs Are Doomed

Prudential Financial Inc. was accused of covering up fraudulent sales of life insurance policies through Wells Fargo & Co. to low-income customers, marking the latest flareup of the fake-accounts scandal plaguing the third-largest U.S. lender by assets.

Many of the customers, who often had Hispanic last names, didn’t know what they had purchased and there were “a large number of similarities” between the way Wells Fargo employees opened bogus bank accounts without customers’ knowledge and the way Prudential’s “MyTerm” policies were sold by the bank, three of the insurer’s former employees said in a lawsuit filed in New Jersey state court.

Wells Fargo, which isn’t a defendant in the lawsuit against Prudential, has eliminated product sales goals that helped fuel the creation of fake accounts by bankers eager for bonuses or fearing being fired.

Top High Tech Stocks To Watch Right Now: John Hancock Tax Advantaged Dividend Income Fund(HTD)

Advisors’ Opinion:

  • [By Stephan Byrd]

    News coverage about John Hancock Tax-Advantage Dvd Incom Fd. (NYSE:HTD) has trended somewhat positive recently, according to Accern. Accern rates the sentiment of media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. John Hancock Tax-Advantage Dvd Incom Fd. earned a news impact score of 0.05 on Accern’s scale. Accern also gave news coverage about the company an impact score of 47.6011591514426 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Top High Tech Stocks To Watch Right Now: The Kraft Heinz Company(KHC)

Advisors’ Opinion:

  • [By Paul Ausick]

    The Kraft Heinz Co. (NASDAQ: KHC) fell about 7% Friday to post a new 52-week low of $67.65 after closing at $72.71 on Thursday. The 52-week high is $97.77. Volume of about 12.8 million was more than three times the daily average. The food processing company reported poor earnings this morning and suggested that sales could get worse as competition increases. 247wallst.com/consumer-products/2018/02/16/how-kraft-heinz-earnings-fell-short/

  • [By ]

    My favorite defensive stock for the coming bear market is Kraft Heinz (Nasdaq: KHC). The stock fits both as a defensive stock and as a stock that has been beat lower — our third bear market search criteria.

  • [By Trey Thoelcke]

    Kraft Heinz Co. (NASDAQ: KHC) is expected to report its first-quarter results late on Wednesday. The analysts consensus forecast is EPS of $0.82 on $6.35 billion in revenue. Shares were changing hands at $57.66 as last week came to a close. The consensus price target is $77.73, and the stock has a 52-week range of $56.11 to $93.88.

  • [By ]

    The packaged food industry has been in a state of flux in recent years, according to Credit Suisse analyst Robert Moskow, as companies like J.M. Smucker Co. (SJM) , Kraft Heinz Co. (KHC) , and others increased their trade spending and made high-priced acquisitions to improve growth rates. 

  • [By Chris Lange]

    It was previously rumored, by the New York Post again, that Kraft Heinz Co. (NASDAQ: KHC) may be looking to gobble up the soup maker. Almost any deal that Campbell might get out of Kraft may just be worth it to the shareholders to get this stock off their hands.

Top High Tech Stocks To Watch Right Now: Mitsubishi Heavy Industries Ltd (MHVYF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Major foreign competitors today now include the French firm Areva (OTCPK:ARVCF) and the Japanese firm Mitsubishi Heavy Industry (OTCPK:MHVYF). This is not a complete list but a focus on major players.

Top High Tech Stocks To Watch Right Now: New York Mortgage Trust Inc.(NYMT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Shares of NY Mtg Tr Inc/SH (NASDAQ:NYMT) have earned an average recommendation of “Hold” from the eight research firms that are presently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and one has given a buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $6.06.

Top Heal Care Stocks To Invest In 2019

Press coverage about Salisbury Bancorp (NASDAQ:SAL) has been trending somewhat positive recently, according to Accern. The research firm identifies positive and negative media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Salisbury Bancorp earned a news sentiment score of 0.19 on Accern’s scale. Accern also gave media stories about the bank an impact score of 43.8549919532618 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:

Top Heal Care Stocks To Invest In 2019: MetLife, Inc.(MET)

Advisors’ Opinion:

  • [By Shane Hupp]

    Traders sold shares of Metlife Inc (NYSE:MET) on strength during trading hours on Friday. $17.86 million flowed into the stock on the tick-up and $48.67 million flowed out of the stock on the tick-down, for a money net flow of $30.81 million out of the stock. Of all equities tracked, Metlife had the 0th highest net out-flow for the day. Metlife traded up $0.32 for the day and closed at $47.41

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on MetLife (MET)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    The Evercore analysts also said that Metlife Inc. (MET) and CNO Financial Group Inc. (CNO) have “sizable exposure” to long-term care from a reserve standpoint, “but our analysis indicates that their blocks have below average risk and/or more robust reserves versus peers, implying a lower risk of charges over the next few years.”

Top Heal Care Stocks To Invest In 2019: Heron Therapeutics, Inc. (HRTX)

Advisors’ Opinion:

  • [By George Budwell]

    Shares of the commercial-stage biotech Heron Therapeutics (NASDAQ:HRTX) gained as much as 36.3% today on abnormally high volume. What triggered this massive surge higher?

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Chris Lange]

    Heron Therapeutics Inc. (NASDAQ: HRTX) shares saw a massive gain on Thursday after the company announced a few key developments. First, the firm provided positive results from its midstage trial, as well as a critical update from the U.S. Food and Drug Administration (FDA).

  • [By George Budwell]

    As things stand now, Cara’s immediate future hinges directly on the strength of Korsuva’s late-stage results in both postoperative pain and CKD-associated pruritus. Having said that, I think investors should largely consider the drug’s postoperative pain indication as icing on the cake at this point. Heron Therapeutics’ (NASDAQ:HRTX)experimental pain medicine HTX-011, after all, appears to have a sizable advantage in terms of efficacy over Korsuva based on the trial data so far. And Heron is almost certainly going to beat Cara to market by several years as well, giving it a formidable first-mover advantage.

Top Heal Care Stocks To Invest In 2019: Intercept Pharmaceuticals, Inc.(ICPT)

Advisors’ Opinion:

  • [By Sean Williams]

    As you can see, there’s a lot of excitement in the NASH space at the moment, and plenty of big drug stocks are itching to add a promising NASH drug to their product pipelines. But one name that continues to be left out in the cold is Intercept Pharmaceuticals (NASDAQ:ICPT).

  • [By Ethan Ryder]

    US Bancorp DE grew its stake in Intercept Pharmaceuticals (NASDAQ:ICPT) by 821.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,751 shares of the biopharmaceutical company’s stock after purchasing an additional 1,561 shares during the period. US Bancorp DE’s holdings in Intercept Pharmaceuticals were worth $108,000 at the end of the most recent quarter.

  • [By Max Byerly]

    News headlines about Intercept Pharmaceuticals (NASDAQ:ICPT) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Intercept Pharmaceuticals earned a news impact score of 0.12 on Accern’s scale. Accern also gave news articles about the biopharmaceutical company an impact score of 46.6381898611919 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Intercept Pharmaceuticals (ICPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Heal Care Stocks To Invest In 2019: Mitsubishi Heavy Industries Ltd (MHVYF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Major foreign competitors today now include the French firm Areva (OTCPK:ARVCF) and the Japanese firm Mitsubishi Heavy Industry (OTCPK:MHVYF). This is not a complete list but a focus on major players.

Top Heal Care Stocks To Invest In 2019: Helen of Troy Limited(HELE)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Now is the time to act. Get out in front of the green wave, and own this stock. It’s legal. The recommendation is free. And you have the opportunity to become a “Marijuana Millionaire” with very little risk. Here’s the pick.

    The Top Stock Market Stories for Monday
    Tariffs are overshadowing the start of earnings season. This week, a variety of Wall Street banks, consumer goods, and airline companies report for the previous quarter. While profits are expected to remain strong, the outlook for the rest of the year is expected to take into account the impact of tariffs on global trade. This is likely to weigh on investor sentiment. According to a report from real estate giant REIS Inc., mall vacancies have hit a six-year high at 8.6% last quarter. The fall of brick-and-mortar stores has been fueled by the rise of Amazon.com Inc.(Nasdaq: AMZN), which continues to see its stock surge to new highs. It’s not too late to get in on Amazon at a fraction of the cost of today’s shares. We’ll show you how… right here. Speaking of Amazon, the e-commerce giant recently made a big splash in the pharmacy benefits business after its purchase of online benefits provider PillPack. This purchase has many analysts convinced that Amazon is about to do to pharmacies what it has done to malls over the last decade. And while Amazon is going to be a major player in the drug-delivery business in the future, there is one stock that is going to stave off any further attack from Amazon and the delivery business. Best of all, this stock has an incredible VQScore, and it’s trading at a huge discount.
    Three Stocks to Watch Today: HOG, TM, TWTR
    A number of companies are reporting that earnings could have a dramatic impact on their future balance sheets. That’s especially true in the transportation business. Harley-Davidson Inc. (NYSE: HOG) has said the tariffs will cost up to $100 million per year and add $2,200 per vehicle. Now, Toyota Motor Corp.(NYSE: TM) has said the tariffs wi

  • [By Ethan Ryder]

    Deer Consumer Products (OTCMKTS: DEER) and Helen of Troy (NASDAQ:HELE) are both consumer discretionary companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk.

  • [By Shane Hupp]

    Helen of Troy (NASDAQ:HELE) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a report released on Saturday.

  • [By Motley Fool Staff]

    Helen of Troy Limited (NYSE: HELE)Q1 2019 Helen Of Troy Limited Earnings Conference callJul. 09, 2018, 1:00 pm ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Steve Symington]

    Shares of Helen of Troy Limited (NASDAQ:HELE) climbed 12.7% on Monday after the consumer brand housewares, health, home, and beauty products company announced strong fiscal first-quarter 2019 results.

  • [By Jim Crumly]

    As for individual stocks, Twitter (NYSE:TWTR) fell on concerns over account deletions, and Helen of Troy (NASDAQ:HELE) jumped after the company reported earnings.

good stocks to invest in now

As Texas considers a “bathroom bill” aimed at transgender individuals, top executives have sent a clear message to the state’s governor: We oppose it.

On Monday, more than 50 business leaders from the Houston area sent a letter to Gov. Greg Abbott, a Republican, asking him to “avoid any actions, including the passage of any ‘bathroom bill,’ that would threaten our continued growth.”

Executives who signed on include the chairman and president of BP America, the CEO of Halliburton (HAL), the CEO of ConocoPhillips (COP), the president of Shell Oil Company and the president of ExxonMobil Global Services Company, a division of ExxonMobil (XOM).

“We support diversity and inclusion, and we believe that any such bill risks harming Texas’ reputation and impacting the state’s economic growth and ability to create new jobs,” the letter reads.

Dallas business leaders sent a similar letter protesting the proposed state law to Abbott earlier this month. That one was signed by Doug Parker, the CEO of American Airlines (AAL), Randall Stephenson, the CEO of AT&T (T, Tech30), and Gary Kelly, the CEO of Southwest Airlines (LUV). (AT&T has agreed to acquire Time Warner, the parent company of CNN. The deal is pending regulatory approval.)

good stocks to invest in now: Mitsubishi Heavy Industries Ltd (MHVYF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Major foreign competitors today now include the French firm Areva (OTCPK:ARVCF) and the Japanese firm Mitsubishi Heavy Industry (OTCPK:MHVYF). This is not a complete list but a focus on major players.

good stocks to invest in now: Humana Inc.(HUM)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Humana Inc. (NYSE: HUM) which rose over 4% to $280.36. The stocks 52-week range is $206.68 to $293.35. Volume was 3.2 million compared to the daily average volume of 1.1 million.

  • [By Paul Ausick]

    Late Thursday, reports began to trickle in that retail behemoth Walmart Inc. (NYSE: WMT) was in preliminary negotiations to acquire health insurer Humana Inc. (NYSE: HUM). Humana’s market cap of around $37 billion makes this a very big deal, even if the talks result in some sort of partnership between the two firms.

  • [By ]

    The deal still needs approval from regulators, but there are fewer potential objections than the attempted tie-up between Aetna and Humana (NYSE: HUM), two insurers. While CVS does manage some drug-benefits plans for employers and insurers through its PBM, the merger wouldn’t create less competition in one particular segment of the industry like the insurance market.

  • [By Ben Levisohn]

    Clinton 15 stock basket (DBUSCLNT): UnitedHealth Group (UNH), Humana (HUM), McKesson (MCK), Aecom (ACM), Quanta Services (PWR), ExxonMobil (XOM), Alcoa (AA), NextEra Energy (NEE), Cree (CREE), First Solar (FSLR), Facebook (FB), Netflix (NFLX), Prudential Financial (PRU), Citigroup (C), Union Pacific (UNP).

  • [By Keith Speights]

    Although Aetna wasn’t successful in its attempted merger with Humana (NYSE:HUM), the blocked deal shouldn’t have too much residual effect. Aetna’s share price remains attractively valued, currently trading at 13 times expected earnings.

  • [By Lisa Levin]

    Humana Inc (NYSE: HUM) delivered better than expected results for the third quarter. However, the company’s adjusted EPS forecast came in below the estimates.

good stocks to invest in now: The Bon-Ton Stores, Inc.(BONT)

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    Lastly, there are a few department-store chains that have been struggling mightily. Sears tops the list, of course. Bon-Ton Stores (NASDAQ:BONT) and Neiman Marcus are also in serious trouble. All three chains have too much debt and have been reporting some of the worst sales results in the industry.

  • [By Peter Graham]

    The Q3 2016 earnings report for small cap department store stock The Bon-Ton Stores, Inc (NASDAQ: BONT)is scheduled for before the market opens on Thursday (November 17th) as traditional department stores continue to struggle to figure out how to attract costumers into their stores as online giants increasingly become thedominant retail players.

  • [By Peter Graham]

    Small cap department store stock The Bon-Ton Stores, Inc (NASDAQ: BONT) reported Q2 2017 earnings before the market opened on Thursday while earnings guidance for the full year fiscal 2017 was reaffirmed. Total sales decreased 7.0% to $504.4 million as comparable store sales decreased 6.1% versus the prior year period. However,double-digit sales growth continued in the omnichannel, which reflects sales via the Company’s website, mobile site, and its Let Us Find It customer service program, as the Company leveraged its West Jefferson facility and store-fulfillment network. The net loss was $33.2 million versus a net loss of $38.7 million.The CEO commented:

  • [By Paul Ausick]

    The Bon-Ton Stores Inc. (NASDAQ: BONT) dropped about 3.3% Thursday to post a new 52-week low of $0.31 after closing Wednesday at $0.32. The 52-week high is $1.98. Volume was around 10 million shares traded, about 100 times the daily average of around 100,000. The struggling retailer had no specific news.

  • [By Peter Graham]

    Small cap department store stock The Bon-Ton Stores, Inc (NASDAQ: BONT)reported fiscalQ1 earnings before the market opened this morning with total salesdown 9.3% to $536.1 million and comparable store sales down 8.8%. Theearnings release noted:

  • [By Adam Levine-Weinberg]

    Not long ago, liquidation seemed inevitable for bankrupt department store operator Bon-Ton Stores Inc. (NASDAQ:BONT). The company’s desperate attempt to restructure outside the bankruptcy process failed earlier this year when it couldn’t find an investor willing to finance a comeback effort.

good stocks to invest in now: Methanex Corporation(MEOH)

Advisors’ Opinion:

  • [By Jim Robertson]

    Back in February of last year, we suggested Methanex Corporation (MEOH), which ended up providing us with some pretty good gains in a fairly short amount of time, and based on what’s happening with the stock technically right now, it could be another gainer over the next several days to few weeks.

good stocks to invest in now: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By WWW.THESTREET.COM]

    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

  • [By Chris Lange]

    Shares of Sage Therapeutics Inc. (NASDAQ: SAGE) saw an incredible gain on Thursday after the firm announced positive top-line results from its midstage trial. Specifically, the firm reported results from its Phase 2 trial of Sage-217 for the treatment of moderate to severe major depressive disorder (MDD).

  • [By Lisa Levin]

    SAGE Therapeutics Inc (NASDAQ: SAGE) shares shot up 73 percent to $159.39 after the company disclosed that Phase 2 trial of SAGE-217 met its primary endpoint.

  • [By WWW.THESTREET.COM]

    The Good

    The market remains resistant (Rs over Ss and Ns). Brokerages, banks and insurance companies continue their league-leading strength. The Russell 2000 Index is up for the 15th consecutive day. Retail extends yesterday’s strength. Nordstrom (JWN) , Macy’s (M) , Best Buy (BBY) , Target (TGT) , Walmart (WMT) , Foot Locker (FL) and JCPenney (JCP) are strong. First day down for Amazon (AMZN) . Agricultural commodities are lackluster, but soybeans are up another up $0.05 today, up substantially for three days in a row. Speculative biotech (Sage (SAGE) , FibroGen (FGEN) , Acadia Pharmaceuticals (ACAD) and Aerie Pharmaceuticals  (AERI) ) stronger after recent weakness. Ag equipment up big time after the Deere (DE) beat.

    The Bad

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.